Stay updated on Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial page.

Latest updates to the Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier was updated from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record now provides details for the completed Phase 2 trial of entinostat plus nivolumab, including eligibility, study design, outcomes, collaborators, and a protocol document. The study is no longer recruiting participants.SummaryDifference59%

- Check22 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH website transition updates and says “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content. The study record itself remains unavailable.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov version as v3.7.1 instead of v3.7.0. The page otherwise remains a 403 error page.SummaryDifference0.2%

Stay in the know with updates to Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat & Nivolumab in Advanced Bile & Pancreas Cancers Clinical Trial page.